We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $111M
1-Year Est. Return 74.4%
This Fund
S&P 500
This Quarter Est. Return
-11.53%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$361M
AUM Growth
+$175M
Cap. Flow
-$2.52M
Cap. Flow %
-0.7%
Top 10 Hldgs %
90.77%
Holding
111
New
18
Increased
19
Reduced
27
Closed
38

Top Buys

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$5.25M
2
TRAW icon
Traws Pharma
TRAW
+$3.96M
3
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
+$1.9M
4
BPTH
Bio-Path Holdings Inc
BPTH
+$1.16M
5
TOPS icon
TOP Ships
TOPS
+$1.13M

Top Sells

Rank Stock Value
1
TEUM
Pareteum Corporation
TEUM
+$2.9M
2
RDGT
Ridgetech Inc
RDGT
+$1.59M
3
CRMD icon
CorMedix
CRMD
+$1.59M
4
ARCT icon
Arcturus Therapeutics
ARCT
+$1.28M
5
ATNM icon
Actinium Pharmaceuticals
ATNM
+$1.27M

Sector Composition

Rank Sector Weight
1 Miscellaneous 94.27%
2 Healthcare 5.45%
3 Industrials 0.18%
4 Technology 0.07%
5 Consumer Discretionary 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRMD icon
76
CorMedix
CRMD
$605M
– –
-249,198
Closed -$1.59M
CRMD icon
77
PUT
CorMedix
CRMD
$605M
– –
-1,936
Closed -$1.24M
CTXR icon
78
Citius Pharmaceuticals
CTXR
$15.4M
– –
-33,817
Closed -$640K
HYPD
79
Hyperion DeFi Inc
HYPD
$51.1M
– –
-224
Closed -$66K
HEPA
80
DELISTED
Hepion Pharmaceuticals
HEPA
– –
-115
Closed -$278K
IMNN icon
81
CALL
Imunon
IMNN
$7.86M
– –
-1
Closed -$40K
OEF icon
82
PUT
iShares S&P 100 ETF
OEF
$20.1B
– –
-1,578
Closed -$23.9M
OPTT icon
83
Ocean Power Technologies
OPTT
$18.5M
– –
-5,000
Closed -$269K
ORMP icon
84
CALL
Oramed Pharmaceuticals
ORMP
$192M
– –
-1,120
Closed -$357K
ORMP icon
85
Oramed Pharmaceuticals
ORMP
$192M
– –
-185,800
Closed -$696K
RKDA icon
86
Arcadia Biosciences
RKDA
$1.04M
– –
-1,251
Closed -$234K
TTNP
87
DELISTED
Titan Pharmaceuticals
TTNP
– –
-139
Closed -$22K
TTNP
88
PUT
DELISTED
Titan Pharmaceuticals
TTNP
– –
0
– -$3K
VXRT
89
DELISTED
Vaxart
VXRT
– –
-1,197,710
Closed -$430K
XTIA icon
90
XTI Aerospace
XTIA
$36.9M
– –
0
– -$275K
RNTX
91
Rein Therapeutics
RNTX
$61M
– –
-27,495
Closed -$368K
RDGT
92
Ridgetech Inc
RDGT
$2.96M
– –
-37
Closed -$1.59M
SEEL
93
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
-128
Closed -$451K
VBIV
94
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
– –
-29,205
Closed -$413K
SOLO
95
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
– –
-288,408
Closed -$587K
DMK
96
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
– –
-2,619
Closed -$127K
BLCM
97
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
– –
-4,201
Closed -$44K
TMDI
98
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
– –
-41,085
Closed -$44K
ADXS
99
DELISTED
Advaxis Inc
ADXS
– –
-1,521,982
Closed -$403K
KDMN
100
PUT
DELISTED
Kadmon Holdings, Inc.
KDMN
– –
-114
Closed -$321K
1 2 3
4
5

Similar funds

IWA
Independent Wealth Advisors Cary, North Carolina $111M AUM
BFA
Ballast Financial Advisors West Chester, Pennsylvania $110M AUM
WPWM
Western Pacific Wealth Management Lake Forest, Illinois $111M AUM 26.64% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
ZS
Zenith Solutions Philadelphia, Pennsylvania $110M AUM
KC
Karras Company Roy, Utah $110M AUM
FI
FinArc Investments Norwood, Massachusetts $110M AUM
CIM
Catalyst Investment Management Windham, New Hampshire $110M AUM

Sabby Management's Q4 2019 Portfolio in Review

As of Q4 2019, Sabby Management held 111 positions worth $361M, up 94% from $186M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Sabby Management's Q4 2019 filing shows 18 new, 19 increased, 27 reduced and 38 closed positions. Its largest new stake was SPDR Gold Trust: 37,550 shares worth $5.37M. The largest sale was Pareteum Corporation, an estimated $2.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 82% a quarter earlier, followed by Healthcare and Industrials.

  • Sabby Management's largest Q4 2019 buy was SPDR Gold Trust: 37,550 shares worth $5.37M.
  • Sabby Management added most to Traws Pharma in Q4 2019, an estimated $3.96M increase.
  • Sabby Management's biggest Q4 2019 reduction was Actinium Pharmaceuticals, cutting an estimated $1.27M.
  • Sabby Management fully exited Pareteum Corporation in Q4 2019, selling an estimated $2.9M.
  • Sabby Management's ten largest holdings make up 91% of its $361M portfolio in Q4 2019.
  • Sabby Management opened 18 new positions and closed 38 in Q4 2019.
  • Sabby Management's portfolio value rose 94% quarter-over-quarter to $361M.

Based on Sabby Management's 13F filing for Q4 2019, filed 14 Feb 2020.